
CV Sciences Investor Relations Material
Latest events

Q2 2025
CV Sciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CV Sciences Inc
Access all reports
CV Sciences Inc. is a life sciences company focused on developing and commercializing products derived from hemp-based cannabidiol (CBD). The company's offerings include consumer health products, such as dietary supplements and topical formulations, that promote wellness and support various health needs. CV Sciences operates through two primary segments: consumer products and drug development. The consumer products division produces CBD-based products under the PlusCBD brand, while the drug development segment is involved in researching CBD-based therapeutics. The company is headquartered in San Diego, California, and its shares are listed on the OTCQB.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
CVSI
Country
🇺🇸 United States